» Articles » PMID: 39525577

Pyroptosis: Induction and Inhibition Strategies for Immunotherapy of Diseases

Overview
Publisher Elsevier
Specialty Pharmacology
Date 2024 Nov 11
PMID 39525577
Authors
Affiliations
Soon will be listed here.
Abstract

Cell death is a central process for organismal health. Pyroptosis, namely pyroptotic cell death, is recognized as a critical type that disrupts membrane and triggers pro-inflammatory cytokine secretion gasdermins, providing a robust form of cytolysis. Meanwhile, along with the thorough research, a great deal of evidence has demonstrated the dual effects of pyroptosis in host defense and inflammatory diseases. More importantly, the recent identification of abundant gasdermin-like proteins in bacteria and fungi suggests an ancient origin of pyroptosis-based regulated cell death in the life evolution. In this review, we bring a general overview of pyroptosis pathways focusing on gasdermin structural biology, regulatory mechanisms, and recent progress in induction and inhibition strategies for disease treatment. We look forward to providing an insightful perspective for readers to comprehend the frame and challenges of the pyroptosis field, and to accelerating its clinical application.

References
1.
Song M, Wang J, Sun Y, Pang J, Li X, Liu Y . Inhibition of gasdermin D-dependent pyroptosis attenuates the progression of silica-induced pulmonary inflammation and fibrosis. Acta Pharm Sin B. 2022; 12(3):1213-1224. PMC: 9069405. DOI: 10.1016/j.apsb.2021.10.006. View

2.
Ruhl S, Shkarina K, Demarco B, Heilig R, Santos J, Broz P . ESCRT-dependent membrane repair negatively regulates pyroptosis downstream of GSDMD activation. Science. 2018; 362(6417):956-960. DOI: 10.1126/science.aar7607. View

3.
Su M, Chen C, Li S, Li M, Zeng Z, Zhang Y . Gasdermin D-dependent platelet pyroptosis exacerbates NET formation and inflammation in severe sepsis. Nat Cardiovasc Res. 2022; 1(8):732-747. PMC: 9362711. DOI: 10.1038/s44161-022-00108-7. View

4.
Jin X, Ma Y, Liu D, Huang Y . Role of pyroptosis in the pathogenesis and treatment of diseases. MedComm (2020). 2023; 4(3):e249. PMC: 10130418. DOI: 10.1002/mco2.249. View

5.
Johnson D, Taabazuing C, Okondo M, Chui A, Rao S, Brown F . DPP8/DPP9 inhibitor-induced pyroptosis for treatment of acute myeloid leukemia. Nat Med. 2018; 24(8):1151-1156. PMC: 6082709. DOI: 10.1038/s41591-018-0082-y. View